```xml
<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<ns3:query_definition xmlns:ns2="http://www.i2b2.org/xsd/cell/crc/psm/1.1/" xmlns:ns4="http://www.i2b2.org/xsd/cell/crc/psm/analysisdefinition/1.1/" xmlns:ns3="http://www.i2b2.org/xsd/cell/crc/psm/querydefinition/1.1/">
    <query_name>  18--Combi-HMG-C@16:15:07</query_name>
    <query_timing>ANY</query_timing>
    <specificity_scale>0</specificity_scale>
    <panel>
        <panel_number>1</panel_number>
        <panel_timing>ANY</panel_timing>
        <panel_accuracy_scale>100</panel_accuracy_scale>
        <invert>0</invert>
        <total_item_occurrences>1</total_item_occurrences>
        <item>
            <hlevel>3</hlevel>
            <item_name>  18-34 years old</item_name>
            <item_key>\\i2b2_DEMO\i2b2\Demographics\Age\18-34 years old\</item_key>
            <item_icon>FA</item_icon>
            <tooltip>Demographics \ Age \ 18-34 years old</tooltip>
            <class>ENC</class>
            <item_is_synonym>false</item_is_synonym>
        </item>
        <item>
            <hlevel>3</hlevel>
            <item_name>  35-44 years old</item_name>
            <item_key>\\i2b2_DEMO\i2b2\Demographics\Age\35-44 years old\</item_key>
            <item_icon>FA</item_icon>
            <tooltip>Demographics \ Age \ 35-44 years old</tooltip>
            <class>ENC</class>
            <item_is_synonym>false</item_is_synonym>
        </item>
        <item>
            <hlevel>3</hlevel>
            <item_name>  45-54 years old</item_name>
            <item_key>\\i2b2_DEMO\i2b2\Demographics\Age\45-54 years old\</item_key>
            <item_icon>FA</item_icon>
            <tooltip>Demographics \ Age \ 45-54 years old</tooltip>
            <class>ENC</class>
            <item_is_synonym>false</item_is_synonym>
        </item>
        <item>
            <hlevel>3</hlevel>
            <item_name>  55-64 years old</item_name>
            <item_key>\\i2b2_DEMO\i2b2\Demographics\Age\55-64 years old\</item_key>
            <item_icon>FA</item_icon>
            <tooltip>Demographics \ Age \ 55-64 years old</tooltip>
            <class>ENC</class>
            <item_is_synonym>false</item_is_synonym>
        </item>
        <item>
            <hlevel>3</hlevel>
            <item_name>  65-74 years old</item_name>
            <item_key>\\i2b2_DEMO\i2b2\Demographics\Age\65-74 years old\</item_key>
            <item_icon>FA</item_icon>
            <tooltip>Demographics \ Age \ 65-74 years old</tooltip>
            <class>ENC</class>
            <item_is_synonym>false</item_is_synonym>
        </item>
        <item>
            <hlevel>3</hlevel>
            <item_name>&gt;= 65 years old</item_name>
            <item_key>\\i2b2_DEMO\i2b2\Demographics\Age\&gt;= 65 years old\</item_key>
            <item_icon>FA</item_icon>
            <tooltip>Demographics \ Age \ &gt;= 65 years old</tooltip>
            <class>ENC</class>
            <item_is_synonym>false</item_is_synonym>
        </item>
        <item>
            <hlevel>3</hlevel>
            <item_name>  75-84 years old</item_name>
            <item_key>\\i2b2_DEMO\i2b2\Demographics\Age\75-84 years old\</item_key>
            <item_icon>FA</item_icon>
            <tooltip>Demographics \ Age \ 75-84 years old</tooltip>
            <class>ENC</class>
            <item_is_synonym>false</item_is_synonym>
        </item>
        <item>
            <hlevel>3</hlevel>
            <item_name>&gt;= 85 years old</item_name>
            <item_key>\\i2b2_DEMO\i2b2\Demographics\Age\&gt;= 85 years old\</item_key>
            <item_icon>FA</item_icon>
            <tooltip>Demographics \ Age \ &gt;= 85 years old</tooltip>
            <class>ENC</class>
            <item_is_synonym>false</item_is_synonym>
        </item>
    </panel>
    <panel>
        <panel_number>2</panel_number>
        <panel_timing>ANY</panel_timing>
        <panel_accuracy_scale>100</panel_accuracy_scale>
        <invert>0</invert>
        <total_item_occurrences>1</total_item_occurrences>
        <item>
            <hlevel>4</hlevel>
            <item_name>Combined hyperlipidemia</item_name>
            <item_key>\\i2b2_DIAG\i2b2\Diagnoses\Metabolic and immunity disorders (270-279)\(272) Disorders of lipoid metabol~\(272-4) Other and unspecified hyp~\</item_key>
            <item_icon>LA</item_icon>
            <tooltip>Diagnoses \ Metabolic and immunity disorders \ Disorders of lipoid metabolism \ Other and unspecified hyperlipidemia</tooltip>
            <class>ENC</class>
            <item_is_synonym>true</item_is_synonym>
        </item>
        <item>
            <hlevel>4</hlevel>
            <item_name>Familial combined hyperlipidemia</item_name>
            <item_key>\\i2b2_DIAG\i2b2\Diagnoses\Metabolic and immunity disorders (270-279)\(272) Disorders of lipoid metabol~\(272-4) Other and unspecified hyp~\</item_key>
            <item_icon>LA</item_icon>
            <tooltip>Diagnoses \ Metabolic and immunity disorders \ Disorders of lipoid metabolism \ Other and unspecified hyperlipidemia</tooltip>
            <class>ENC</class>
            <item_is_synonym>true</item_is_synonym>
        </item>
        <item>
            <hlevel>4</hlevel>
            <item_name>Familial multiple lipoprotein-type hyperlipidemia</item_name>
            <item_key>\\i2b2_DIAG\i2b2\Diagnoses\Metabolic and immunity disorders (270-279)\(272) Disorders of lipoid metabol~\(272-4) Other and unspecified hyp~\</item_key>
            <item_icon>LA</item_icon>
            <tooltip>Diagnoses \ Metabolic and immunity disorders \ Disorders of lipoid metabolism \ Other and unspecified hyperlipidemia</tooltip>
            <class>ENC</class>
            <item_is_synonym>true</item_is_synonym>
        </item>
        <item>
            <hlevel>4</hlevel>
            <item_name>Group A hyperlipidemia</item_name>
            <item_key>\\i2b2_DIAG\i2b2\Diagnoses\Metabolic and immunity disorders (270-279)\(272) Disorders of lipoid metabol~\(272-0) Pure hypercholesterolemia\</item_key>
            <item_icon>LA</item_icon>
            <tooltip>Diagnoses \ Metabolic and immunity disorders \ Disorders of lipoid metabolism \ Pure hypercholesterolemia</tooltip>
            <class>ENC</class>
            <item_is_synonym>true</item_is_synonym>
        </item>
        <item>
            <hlevel>4</hlevel>
            <item_name>Group B hyperlipidemia</item_name>
            <item_key>\\i2b2_DIAG\i2b2\Diagnoses\Metabolic and immunity disorders (270-279)\(272) Disorders of lipoid metabol~\(272-1) Pure hyperglyceridemia\</item_key>
            <item_icon>LA</item_icon>
            <tooltip>Diagnoses \ Metabolic and immunity disorders \ Disorders of lipoid metabolism \ Pure hyperglyceridemia</tooltip>
            <class>ENC</class>
            <item_is_synonym>true</item_is_synonym>
        </item>
        <item>
            <hlevel>4</hlevel>
            <item_name>Group D hyperlipidemia</item_name>
            <item_key>\\i2b2_DIAG\i2b2\Diagnoses\Metabolic and immunity disorders (270-279)\(272) Disorders of lipoid metabol~\(272-3) Hyperchylomicronemia\</item_key>
            <item_icon>LA</item_icon>
            <tooltip>Diagnoses \ Metabolic and immunity disorders \ Disorders of lipoid metabolism \ Hyperchylomicronemia</tooltip>
            <class>ENC</class>
            <item_is_synonym>true</item_is_synonym>
        </item>
        <item>
            <hlevel>4</hlevel>
            <item_name>Hyperlipidemia</item_name>
            <item_key>\\i2b2_DIAG\i2b2\Diagnoses\Metabolic and immunity disorders (270-279)\(272) Disorders of lipoid metabol~\(272-4) Other and unspecified hyp~\</item_key>
            <item_icon>LA</item_icon>
            <tooltip>Diagnoses \ Metabolic and immunity disorders \ Disorders of lipoid metabolism \ Other and unspecified hyperlipidemia</tooltip>
            <class>ENC</class>
            <item_is_synonym>true</item_is_synonym>
        </item>
        <item>
            <hlevel>4</hlevel>
            <item_name>Hyperlipidemia, combined</item_name>
            <item_key>\\i2b2_DIAG\i2b2\Diagnoses\Metabolic and immunity disorders (270-279)\(272) Disorders of lipoid metabol~\(272-4) Other and unspecified hyp~\</item_key>
            <item_icon>LA</item_icon>
            <tooltip>Diagnoses \ Metabolic and immunity disorders \ Disorders of lipoid metabolism \ Other and unspecified hyperlipidemia</tooltip>
            <class>ENC</class>
            <item_is_synonym>true</item_is_synonym>
        </item>
        <item>
            <hlevel>4</hlevel>
            <item_name>Hyperlipidemia, Group A</item_name>
            <item_key>\\i2b2_DIAG\i2b2\Diagnoses\Metabolic and immunity disorders (270-279)\(272) Disorders of lipoid metabol~\(272-0) Pure hypercholesterolemia\</item_key>
            <item_icon>LA</item_icon>
            <tooltip>Diagnoses \ Metabolic and immunity disorders \ Disorders of lipoid metabolism \ Pure hypercholesterolemia</tooltip>
            <class>ENC</class>
            <item_is_synonym>true</item_is_synonym>
        </item>
        <item>
            <hlevel>4</hlevel>
            <item_name>Hyperlipidemia, Group B</item_name>
            <item_key>\\i2b2_DIAG\i2b2\Diagnoses\Metabolic and immunity disorders (270-279)\(272) Disorders of lipoid metabol~\(272-1) Pure hyperglyceridemia\</item_key>
            <item_icon>LA</item_icon>
            <tooltip>Diagnoses \ Metabolic and immunity disorders \ Disorders of lipoid metabolism \ Pure hyperglyceridemia</tooltip>
            <class>ENC</class>
            <item_is_synonym>true</item_is_synonym>
        </item>
        <item>
            <hlevel>4</hlevel>
            <item_name>Hyperlipidemia, Group D</item_name>
            <item_key>\\i2b2_DIAG\i2b2\Diagnoses\Metabolic and immunity disorders (270-279)\(272) Disorders of lipoid metabol~\(272-3) Hyperchylomicronemia\</item_key>
            <item_icon>LA</item_icon>
            <tooltip>Diagnoses \ Metabolic and immunity disorders \ Disorders of lipoid metabolism \ Hyperchylomicronemia</tooltip>
            <class>ENC</class>
            <item_is_synonym>true</item_is_synonym>
        </item>
        <item>
            <hlevel>4</hlevel>
            <item_name>Hyperlipidemia NOS</item_name>
            <item_key>\\i2b2_DIAG\i2b2\Diagnoses\Metabolic and immunity disorders (270-279)\(272) Disorders of lipoid metabol~\(272-4) Other and unspecified hyp~\</item_key>
            <item_icon>LA</item_icon>
            <tooltip>Diagnoses \ Metabolic and immunity disorders \ Disorders of lipoid metabolism \ Other and unspecified hyperlipidemia</tooltip>
            <class>ENC</class>
            <item_is_synonym>true</item_is_synonym>
        </item>
        <item>
            <hlevel>4</hlevel>
            <item_name>Hyperlipidemia, other and unspecified</item_name>
            <item_key>\\i2b2_DIAG\i2b2\Diagnoses\Metabolic and immunity disorders (270-279)\(272) Disorders of lipoid metabol~\(272-4) Other and unspecified hyp~\</item_key>
            <item_icon>LA</item_icon>
            <tooltip>Diagnoses \ Metabolic and immunity disorders \ Disorders of lipoid metabolism \ Other and unspecified hyperlipidemia</tooltip>
            <class>ENC</class>
            <item_is_synonym>true</item_is_synonym>
        </item>
        <item>
            <hlevel>4</hlevel>
            <item_name>Mixed hyperlipidemia</item_name>
            <item_key>\\i2b2_DIAG\i2b2\Diagnoses\Metabolic and immunity disorders (270-279)\(272) Disorders of lipoid metabol~\(272-2) Mixed hyperlipidemia\</item_key>
            <item_icon>LA</item_icon>
            <tooltip>Diagnoses \ Metabolic and immunity disorders \ Disorders of lipoid metabolism \ Mixed hyperlipidemia</tooltip>
            <class>ENC</class>
            <item_is_synonym>true</item_is_synonym>
        </item>
        <item>
            <hlevel>4</hlevel>
            <item_name>Multiple-type hyperlipidemia</item_name>
            <item_key>\\i2b2_DIAG\i2b2\Diagnoses\Metabolic and immunity disorders (270-279)\(272) Disorders of lipoid metabol~\(272-4) Other and unspecified hyp~\</item_key>
            <item_icon>LA</item_icon>
            <tooltip>Diagnoses \ Metabolic and immunity disorders \ Disorders of lipoid metabolism \ Other and unspecified hyperlipidemia</tooltip>
            <class>ENC</class>
            <item_is_synonym>true</item_is_synonym>
        </item>
        <item>
            <hlevel>4</hlevel>
            <item_name>Other and unspecified hyperlipidemia</item_name>
            <item_key>\\i2b2_DIAG\i2b2\Diagnoses\Metabolic and immunity disorders (270-279)\(272) Disorders of lipoid metabol~\(272-4) Other and unspecified hyp~\</item_key>
            <item_icon>LA</item_icon>
            <tooltip>Diagnoses \ Metabolic and immunity disorders \ Disorders of lipoid metabolism \ Other and unspecified hyperlipidemia</tooltip>
            <class>ENC</class>
            <item_is_synonym>true</item_is_synonym>
        </item>
    </panel>
    <panel>
        <panel_number>3</panel_number>
        <panel_timing>ANY</panel_timing>
        <panel_accuracy_scale>100</panel_accuracy_scale>
        <invert>0</invert>
        <total_item_occurrences>1</total_item_occurrences>
        <item>
            <hlevel>3</hlevel>
            <item_name>HMG-CoA reductase inhibitors</item_name>
            <item_key>\\i2b2_MEDS\i2b2\Medications\MUL\(LME5) antihyperlipidemic agents\(LME8) HMG-CoA reductase inhibitors\</item_key>
            <item_icon>FA</item_icon>
            <tooltip>medications \ antihyperlipidemic agents \ hmg-coa reductase inhibitors</tooltip>
            <class>ENC</class>
            <item_is_synonym>false</item_is_synonym>
        </item>
    </panel>
</ns3:query_definition>

```

I want to find all patients with a diagnosis of hyperlipidemia, including different types such as Type I, Type II, Type III, Type IV, Type V, and mixed hyperlipidemia, as well as other unspecified hyperlipidemia, and prescriptions for HMG-CoA reductase inhibitors.